Hermansky-Pudlak syndrome 2 is an autosomal recessive disorder caused by mutations of the AP3B1 gene. It is characterized by oculocutaneous albinism, bleeding disorder and, in some cases, pulmonary fibrosis or granulomatous colitis.
| 1. |
Kotzot D et al. (1994) Oculocutaneous albinism, immunodeficiency, hematological disorders, and minor anomalies: a new autosomal recessive syndrome?
|
| 2. |
Dell'Angelica EC et al. (1999) Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor.
|
| 3. |
Huizing M et al. (2002) Nonsense mutations in ADTB3A cause complete deficiency of the beta3A subunit of adaptor complex-3 and severe Hermansky-Pudlak syndrome type 2.
|
| 4. |
Clark RH et al. (2003) Adaptor protein 3-dependent microtubule-mediated movement of lytic granules to the immunological synapse.
|
| 5. |
Jung J et al. (2006) Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2.
|
| 6. |
Enders A et al. (2006) Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II.
|
| 7. |
None (1999) Multi-organellar disorders of pigmentation: tied up in traffic.
|
| 8. |
Sugita M et al. (2002) Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells.
|
| 9. |
Fontana S et al. (2006) Innate immunity defects in Hermansky-Pudlak type 2 syndrome.
|